Ischemic Heart Disease | Myocardial Infarction | |||||
---|---|---|---|---|---|---|
Negative | Positive (%) | OR (95% CI) | Negative | Positive (%) | OR (95% CI) | |
VEGFA–2578 (A/C) | ||||||
CC | 98 | 9 (8.4) | 1.0 (referent) | 105 | 2 (1.9) | 1.0 (referent) |
AC | 154 | 47 (23.4) | 3.19 (1.52–6.69) | 167 | 34 (16.9) | 8.69 (2.35–32.10) |
AA | 88 | 22 (20.0) | 2.63 (1.17–5.93) | 100 | 10 (9.1) | 4.41 (1.08–17.99) |
A allele | 242 | 69 (22.2) | 2.97 (1.45–6.09) | 267 | 44 (14.1) | 7.02 (1.93–25.60) |
VEGFA–460 (T/C) | ||||||
TT | 93 | 11 (10.6) | 1.0 (referent) | 100 | 4 (3.8) | 1.0 (referent) |
CT | 165 | 45 (21.4) | 2.23 (1.15–4.48) | 179 | 31 (14.8) | 3.91 (1.42–10.84) |
CC | 82 | 22 (21.2) | 2.22 (1.03–4.79) | 93 | 11 (10.6) | 2.75 (0.89–8.47) |
C allele | 247 | 67 (21.3) | 2.22 (1.14–4.33) | 272 | 42 (13.4) | 3.48 (1.28–9.45) |
VEGFA+405 (C/G) | ||||||
CC | 36 | 4 (10.0) | 1.0 (referent) | 39 | 1 (2.5) | 1.0 (referent) |
CG | 146 | 32 (18.0) | 1.80 (0.63–5.14) | 159 | 19 (10.7) | 3.22 (0.59–17.57) |
GG | 158 | 42 (21.0) | 2.17 (0.77–6.13) | 174 | 26 (13.0) | 3.99 (0.74–21.47) |
G allele | 304 | 74 (19.6) | 1.98 (0.72–5.46) | 333 | 45 (11.9) | 3.59 (0.68–18.89) |
VEGFA+936 (T/C) | ||||||
TT | 11 | 3 (21.4) | 1.0 (referent) | 13 | 1 (7.1) | 1.0 (referent) |
CT | 89 | 14 (13.6) | 0.53 (0.14–1.99) | 95 | 8 (7.8) | 0.80 (0.13–4.98) |
CC | 240 | 61 (20.3) | 0.84 (0.24–2.87) | 264 | 37 (12.3) | 1.28 (0.23–7.13) |
— |